Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
ICICI Pru Nifty Pharma Index Fund Reg (G)
[Equity: Index]  
 
Fund Details
Fund Type Growth Launch Date 14-Dec-22
Corpus(Cr.) 163.00 Latest NAV 20.1693 As on 29-10-2026
Equity(%) 99.93 52 Week High 20.5641
Debt(%) 0.07 52 Week Low 16.3191
Others(%) 0.00 Exit Load 0
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark NIFTY Pharma TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Ashwini Jemin Bharucha
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 54.59%
Top 10 Holdings 78.15%
Top 25 Holdings 100.00%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 99.93
Cash 0.07
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.25
PE Ratio 40.51
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Ltd. 19.50
Divis Laboratories Ltd. 11.97
Laurus Labs Limited 7.82
Cipla Ltd. 7.68
Dr. Reddys Laboratories Ltd. 7.62
Torrent Pharmaceuticals Ltd. 7.16
Lupin Ltd 5.00
Aurobindo Pharma Ltd. 4.68
Glenmark Pharmaceuticals ltd 3.56
Alkem Laboratories Limited 3.16
Zydus Lifesciences Limited 2.92
Mankind Pharma Limited 2.88
Ipca Laboratories Ltd. 2.71
Biocon Ltd. 2.62
Gland Pharma Limited 2.34
Sai Life Sciences Limited 2.14
Wockhardt Ltd 1.77
Ajanta Pharma Ltd. 1.67
TREPS 1.50
Abbott India Ltd. 1.43
PIRAMAL PHARMA LIMITED 1.30
Net Current Assets -1.43

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.92% 1.05% 14.58% 18.42%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Realty]
-1.69% -10.74% 1.76% -13.75%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
8.29% 21.16% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
-9.54% 12.00% 10.45% 14.55%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
ICICI Pru Nifty Pharma Index Fund Reg (G) 16.15% 0.0000 0.0000% 0.0000 0.0000
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
ICICI Pru Nifty Pharma Index Fund Reg (G) 0.0000% 0.0000 0.0000 0.0000 0.0000
 
Back to Selection